Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral glioma

Journal of Clinical Oncology

Volumn 29, Issue 32, 2011, Pages 4307-4312

  Rooney, Alasdair G ^a   McNamara, Shanne ^a   Mackinnon, Mairi ^b   Fraser, Mary ^b   Rampling, Roy ^b   Carson, Alan ^a   Grant, Robin ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; DEXAMETHASONE; TEMOZOLOMIDE;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEPRESSION; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE DURATION; EPILEPSY; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL HISTORY; MENTAL DETERIORATION; MULTICENTER STUDY; NEUROSURGERY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TREATMENT DURATION;

ADULT; AGED; BRAIN NEOPLASMS; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GLIOMA; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 81155123188     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.34.8466     Document Type: Article

References (24)

1. Central Brain Tumor Registry of the United States (CBTRUS): CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2006. Hinsdale, IL, Central Brain Tumor Registry of the United States, 2010
2. Stupp R, Mason WP, van den Bent MJ, et al.: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005 (Pubitemid 40349501)
3. Rooney AG, Carson A, Grant R: Depression in cerebral glioma patients: A systematic review of observational studies. J Natl Cancer Inst 103:61-76, 2011
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Text Revision (ed 4). Washington, DC, American Psychiatric Association, 2000
5. Wellisch DK, Kaleita TA, Freeman D, et al.: Predicting major depression in brain tumor patients. Psychooncology 11:230-238, 2002 (Pubitemid 34618588)
6. Siegel AM, Cascino GD, Fessler AJ, et al.: Psychiatric comorbidity in 75 patients undergoing epilepsy surgery: Lack of correlation with pathological findings. Epilepsy Res 80:158-162, 2008
7. Litofsky NS, Farace E, Anderson F Jr, et al.: Depression in patients with high-grade glioma: Results of the Glioma Outcomes Project. Neurosurgery 54:358-366, 2004
8. D'Angelo C, Mirijello A, Leggio L, et al.: State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1-year longitudinal study. J Neurosurg 108:281-286, 2008 (Pubitemid 351213291)
9. First MB, Gibbon M, Spitzer RL, et al.: User's Guide for the SCID-I, Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version. New York, NY, New York State Psychiatric Institute, 1996
10. Ring HA, Moriarty J, Trimble MR: A prospective study of the early postsurgical psychiatric associations of epilepsy surgery. J Neurol Neurosurg Psychiatry 64:601-604, 1998 (Pubitemid 28204145)
11. Sharpe M, Strong V, Allen K, et al.: Major depression in outpatients attending a regional cancer centre: Screening and unmet treatment needs. Br J Cancer 90:314-320, 2004 (Pubitemid 38250622)
12. Hoffman MA, Weiner JS: Is Mrs S depressed? Diagnosing depression in the cancer patient. J Clin Oncol 25:2853-2856, 2007 (Pubitemid 47123198)
13. Mioshi E, Dawson K, Mitchell J, et al.: The Addenbrooke's Cognitive Examination Revised (ACE-R): A brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078-1085, 2006 (Pubitemid 44762726)
14. Karnovsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer, in MacLeod CM (ed): Evaluation of Chemotherapeutic Agents. New York, NY, Colombia University Press, 1949, pp 191-205
15. Lwanga SK, Lemeshow S: Sample Size Determination in Health Studies: A Practical Manual. Geneva, Switzerland, WHO, 1991
16. Peduzzi P, Concato J, Kemper T, et al.: A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373-1379, 1996 (Pubitemid 27028925)
17. Anderson SI, Taylor R, Whittle IR: Mood disorders in patients after treatment for primary intracranial tumours. Br J Neurosurg 13:480-485, 1999 (Pubitemid 29457381)
18. Hotopf M, Chidgey J, Addington-Hall J, et al.: Depression in advanced disease: A systematic review. Part 1: Prevalence and case finding. Palliat Med 16:81-97, 2002 (Pubitemid 34326513)
19. Pasquini M, Biondi M: Depression in cancer patients: A critical review. Clin Pract Epidemiol Ment Health 3:2, 2007
20. Arnold SD, Forman LM, Brigidi BD, et al.: Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro Oncol 10:171-181, 2008
21. Kaplan CP, Miner ME: Relationships: Importance for patients with cerebral tumours. Brain Inj 14:251-259, 2000 (Pubitemid 30179156)
22. Mainio A, Hakko H, Niemela A, et al.: Depression and functional outcome in patients with brain tumors: A population-based 1-year follow-up study. J Neurosurg 103:841-847, 2005 (Pubitemid 43194578)
23. Williams S, Dale J: The effectiveness of treatment for depression/depressive symptoms in adults with cancer: A systematic review. Br J Cancer 94:372-390, 2006 (Pubitemid 43237562)
24. Angst J: Course and prognosis of mood disorders, in Gelder MG, Lopez-Ibor JJ, Andreasen N (eds): New Oxford Textbook of Psychiatry (ed 2). New York, NY, Oxford University Press, 2009